Drug name

Dose\
route

Action

NAME OF
Increase the
Po
THE DRUG:
release of
Methylphenidate
nor
20-30 mg/
epinephrine
TRADE
day (oral) dopamine in
NAME: retalin
cerebral
cortex to
FUNCTIONAL
reticular
CLASS: cns
activating
stimulant
system
wxact
CHEMICAL
action not
CLASS:
known
piperidine
derivatives

Indication
Attention
deficit
disorder,
hyperactivity
disorder,
narcolepsy,
depression,
obesity.

Contraindication

Side effects

Breast
feeding,
hyper
sensitivity
,
Agitation,
Glaucoma
, Tics,
Monoamin
e Oxidase
Inhibitors.

Cardiac:
Asses:
angina,
Asses mental status,
arrhythmia,
palpitations,
anxiety, mood, sleeping
pulse increased
pattern, drowsiness,
or decreased,
dizziness, especially in
tachycardia
geriatric pt.
Gastrointestin
al: abdominal
pain, nausea
Immune:
hyper
sensitivity
reactions
including skin
rash, urticaria,
fever,
arthralgia,
exfoliative
dermatitis,
erythema
multiforme
with histo
pathological
findings of
necrotizing
vasculitis, and

Nurses responsibilities

Asses BP lying, standing;

pulse if systolic BP drops
20mm/hg, hold the
product and notify
prescriber.
Perform and provide:
Tablets may be crushed,
mixed with food or fluids,
if unable to swallow
medication.
Perform to discontinue,
decrease the dose of drug.
Administer IV fluids
Adminster analgesics.
Evaluate:
Therapeutic response
decreases, anxiety,
restlessness and

thrombo
cytopenic
purpura.
Metabolism/
Nutrition:
anorexia,
weight loss
during
prolonged
therapy
Nervous
System:
dizziness,
drowsiness,
dyskinesia,
headache, rare
reports of
Tourette's
syndrome,
toxic psychosis
Vascular:
blood pressure
increased or
decreased;
cerebrovascula
rvasculitis;
cerebral
occlusions;
cerebral

sleeplessness.

FAMILY PATIENT
TEACHING:
Teach the patient that
product may be taken
with food
Inform the pt to avoid
OTC preparations unless
approved by prescriber
Inform the patient to
avoid driving activites
that require aletness, since
drowsiness may occur.
Inform the pt that sore can
occur, take hard candy,
gum or sips of water may
relieve dry mouth
Instruct the pt to change
positions slowly from
recumbent to sitting,
before standing to prevent
dizziness.

hemorrhages
and cerebro
vascular
accidents
Blood/
Lymphatic:
leukopenia
and/or anemia
Hepatobiliary:
abnormal liver
function,
ranging from
transaminase
elevation to
hepatic coma
Psychiatric:
transient
depressed
mood,
aggressive
behavior
Skin/Subcutan
eous: scalp
hair loss

Encourage the pt to stop

smoking reduce
alprazolam effectiveness.
Inform the patient that
drowsiness usually
disappears with conitinue
therapy.
CONCLUSION:
Provided suggestion,
discussed about the drug
and enhance the general
instructions to be
followed while receiving
this drug.

CNS STIMULANT
PREAPRED BY: A.Abinesh (14N00601)
YR/SEM: 3rd yr/ 5th sem

METHYLPHENIDATE